Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Prospective, unmasked, randomized evaluation of the iStent in patients with primary
open-angle glaucoma. Patients will be randomized to one of two groups: 1) iStent, or 2)
medication.